Anastrozole Tablet
Product Images NDC 68071-5329

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Anastrozole (NDC 68071-5329). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

7b4ba0c5 0287 B7a7 E053 2991aa0a575e

Anastrozole 1 mg oral tablets, round white tablets embossed with 'YL' on one side and '111' on the other, as manufactured by NuCare Pharmaceuticals, Inc.*

FDA Label Image

Chemical Structure For Anastrozole (Image 01)

Chemical structure of Anastrozole, showing its molecular arrangement with a benzene ring substituted by two nitrile groups and a triazole ring attached via a methylene linkage.*

FDA Label Image

Figure 1 (Image 02)

A line chart displaying disease-free survival over 90 months comparing anastrozole and tamoxifen treatments. The y-axis shows the proportion alive and disease-free, starting near 1.0 and declining over time. The x-axis indicates disease-free survival in months. A table beneath lists the number of patients at risk for each treatment group at various times.*

FDA Label Image

Figure 2 (Image 03)

A survival curve chart comparing disease-free survival in months for patients treated with anastrozole versus tamoxifen. The y-axis represents the proportion alive and disease-free, while the x-axis shows time up to 90 months. The chart includes patient counts at risk for both treatments over time.*

FDA Label Image

Figure 3 (Image 04)

A Kaplan-Meier survival curve chart showing the proportion event-free over time (in months) for two randomized treatments: Anastrozole and Tamoxifen. The graph illustrates patient survival data up to 120 months, with the number of patients at risk listed below the time axis for both treatments at multiple intervals.*

FDA Label Image

Figure 4 (Image 05)

Kaplan-Meier survival curves comparing Anastrozole and Tamoxifen treatments over time (months). The y-axis represents the proportion of event-free patients, and the x-axis shows time to event in months up to 120 months. The chart includes the number of patients at risk at various time points for each treatment group.*

FDA Label Image

Figure 5 (Image 06)

A line graph comparing the proportion not progressing over time (months) for Anastrozole and Tamoxifen treatments. The x-axis shows time to progression in months, while the y-axis shows the proportion not progressing. Anastrozole is represented by a solid line and Tamoxifen by a dashed line, illustrating differences in progression rates during the study period.*

FDA Label Image

Figure 6 (Image 07)

A survival curve chart comparing time to progression in months between two randomized treatments: Anastrozole and Tamoxifen. The y-axis represents the proportion not progressing, while the x-axis shows months. Numbers at risk for each treatment are listed below the timeline, illustrating patient counts over time.*

FDA Label Image

Avet Logo (Avet)

FDA Label Image

Jpg (68071 5329 3)

Anastrozole 1 mg tablets packaging label by NuCare Pharmaceuticals, Inc. The label indicates a 30-count tablet bottle. Tablets contain 1 mg Anastrozole USP, described as circular, white, biconvex, with identifiable markings. Label includes storage instructions at controlled temperature 68-77°F and warnings to keep out of reach of children. The NDC code is 68071-5329-3.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.